To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Inconclusive efficacy of Chinese herbal medication in osteoarthritis treatment

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2014

Inconclusive efficacy of Chinese herbal medication in osteoarthritis treatment

Vol: 3| Issue: 3| Number:18| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Efficacy of individualized Chinese herbal medication in osteoarthrosis of hip and knee: a double-blind, randomized-controlled clinical study

J Altern Complement Med. 2011 Jun;17(6):539-47. doi: 10.1089/acm.2010.0602

Contributing Authors:
M Lechner I Steirer B Brinkhaus Y Chen C Krist-Dungl A Koschier M Gantschacher K Neumann A Zauner-Dungl

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Research into effective treatments for osteoarthritis (OA) is ongoing. In this trial, 102 patients with knee or hip OA were randomized to receive specific, active or nonspecific, control herbal therapy on the basis of Traditional Chinese Medicine. The purpose was to determine whether active preparations of low-dose Chinese herbs provided a stark reduction in symptoms associated with OA. After 20 w...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue